The premier social-equity license-to-license provider in California.
LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / Green Label Rx, a pioneering force in the cannabis industry, proudly announces the grand opening of its first retail location in Canoga Park on Saturday, August 24. This milestone marks the culmination of a 25-year journey for founder Jason McKnight, a legacy operator, and social equity license holder, and the final step in creating a completely vertical seed-to-sale cannabis company.
With over two decades of experience, McKnight and his wife Kelly have been steadfast advocates for the cannabis community, ensuring that Green Label Rx upholds the highest standards of quality, sustainability, and social responsibility. In collaboration with their partner and fellow social equity license holder Michael Asseraf, the new retail location will offer a curated selection of premium cannabis products, reflecting the company’s commitment to excellence and innovation.
“Opening this storefront is a dream come true,” said McKnight. “It’s a testament to our dedication to the industry and community. We are excited to provide a welcoming and educational environment for new and experienced cannabis consumers.”
As the premier social-equity license-to-license provider in the state, Green Label RX’s first dispensary opening brings an expanded commitment to equitable ownership and employment opportunities in the cannabis industry.
For more information, visit www.greenlabelrx.com.
Interested in covering or attending the grand opening ceremony? Looking to feature a cannabis brand, please contact:
SOURCE: Green Label Rx
View the original press release on accesswire.com
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance…
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…